Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hinge Health, Inc.HNGE · Entity 377 | Chief Financial Officer | October 12, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hinge Health, Inc.
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 296,728 |
Ending reported balance
After 2026-10-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-10-12 · Sale · Disposed 2,100 · Balance 342,348 F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F2: Represents the weighted average sale price. The lowest price at which shares were sold was $101.00 and the highest price at which shares were sold was $101.93. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Row 2 · 2026-10-12 · Sale · Disposed 21,702 · Balance 320,646 F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F3: Represents the weighted average sale price. The lowest price at which shares were sold was $102.01 and the highest price at which shares were sold was $103.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Row 3 · 2026-10-12 · Sale · Disposed 14,498 · Balance 306,148 F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F4: Represents the weighted average sale price. The lowest price at which shares were sold was $103.01 and the highest price at which shares were sold was $103.99. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Row 4 · 2026-10-12 · Sale · Disposed 9,420 · Balance 296,728 F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F5: Represents the weighted average sale price. The lowest price at which shares were sold was $104.02 and the highest price at which shares were sold was $104.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
F2: Represents the weighted average sale price. The lowest price at which shares were sold was $101.00 and the highest price at which shares were sold was $101.93. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F3: Represents the weighted average sale price. The lowest price at which shares were sold was $102.01 and the highest price at which shares were sold was $103.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F4: Represents the weighted average sale price. The lowest price at which shares were sold was $103.01 and the highest price at which shares were sold was $103.99. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F5: Represents the weighted average sale price. The lowest price at which shares were sold was $104.02 and the highest price at which shares were sold was $104.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Pluralsight, Inc.
Report date April 06, 2021 · Filed April 08, 2021
Section 16 reporting ended · disclosed 2021-04-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-04-06 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2021-04-06 · Other · Disposed 51,220 · Balance 127,651 F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). Row 2 · 2021-04-06 · Other · Disposed 74,545 · Balance 53,106 F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). F2: Includes balance of 74,545 unvested restricted share units ("RSUs") which vest quarterly through January 1, 2024 and subject to the Reporting Person's continued service through each vesting date. In connection with the Offer, the unvested RSUs were cancelled and converted into the contingent right to receive a cash payment of $1,677,263, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested RSUs for which such cash amount was exchanged would have vested pursuant to its terms. Row 3 · 2021-04-06 · Other · Disposed 53,106 · Balance 0 F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). F3: Includes 53,106 shares of unvested RSUs awarded upon the achievement of certain performance metrics that will vest annually, in two equal installments, through January 1, 2023. In connection with the Offer, the unvested RSUs were cancelled and converted into the contingent right to receive a cash payment of $1,194,885, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested RSUs for which such cash amount was exchanged would have vested pursuant to its terms. Row 4 · 2021-04-06 · Exercise / conversion · Acquired 150,080 · Balance 150,080 F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). Row 5 · 2021-04-06 · Other · Disposed 150,080 · Balance 0 F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 66,423 |
Reported balance
After 2021-04-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-06 · Exercise / conversion · Disposed 150,080 · Balance 66,423 F4: One share of the Issuer's Class B common stock (the "Class B Common Stock") was issued for each limited liability company unit of Pluralsight Holdings, LLC (each an "LLC Unit") held by the reporting person pursuant to a reclassification of Pluralsight Holdings, LLC that occurred prior to the Issuer's initial public offering. The shares of Class B Common Stock (i) confer no incidents of economic ownership on the holders thereof and (ii) only confer one-to-one voting rights on the holders thereof. Each share of Class B Common Stock and corresponding LLC Unit is redeemable or exchangeable for one share of Class A Common Stock at the option of the holder (for which the Issuer may substitute cash) and has no expiration date. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-06 · Other · Disposed 66,423 · Balance 0 F5: Includes 66,423 shares of Class B Common Stock issued for each unvested incentive LLC Unit and subject to a right of repurchase in favor of Pluralsight, which will vest on April 17, 2021. In connection with the Offer, the shares of Class B Common Stock and corresponding incentive LLC Units were cancelled and converted into the contingent right to receive a cash payment of $1,494,518, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested incentive LLC Units for which such cash amount was exchanged would have vested pursuant to their terms. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2028-05-17 | Direct | 0 |
Reported balance
After 2021-04-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-06 · Other · Disposed 537,503 · Balance 0 F6: Includes 537,503 shares subject to the option vest in four equal semiannual installments beginning on November 17, 2018. In connection with the Offer, the options were cancelled and converted into a cash payment of $4,031,273, which represents $22.50 for each share of Class A Common Stock subject the options minus the exercise price per share of $15.00, payable in connection with the consummation of the Offer. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options).
F2: Includes balance of 74,545 unvested restricted share units ("RSUs") which vest quarterly through January 1, 2024 and subject to the Reporting Person's continued service through each vesting date. In connection with the Offer, the unvested RSUs were cancelled and converted into the contingent right to receive a cash payment of $1,677,263, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested RSUs for which such cash amount was exchanged would have vested pursuant to its terms.
F3: Includes 53,106 shares of unvested RSUs awarded upon the achievement of certain performance metrics that will vest annually, in two equal installments, through January 1, 2023. In connection with the Offer, the unvested RSUs were cancelled and converted into the contingent right to receive a cash payment of $1,194,885, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested RSUs for which such cash amount was exchanged would have vested pursuant to its terms.
F4: One share of the Issuer's Class B common stock (the "Class B Common Stock") was issued for each limited liability company unit of Pluralsight Holdings, LLC (each an "LLC Unit") held by the reporting person pursuant to a reclassification of Pluralsight Holdings, LLC that occurred prior to the Issuer's initial public offering. The shares of Class B Common Stock (i) confer no incidents of economic ownership on the holders thereof and (ii) only confer one-to-one voting rights on the holders thereof. Each share of Class B Common Stock and corresponding LLC Unit is redeemable or exchangeable for one share of Class A Common Stock at the option of the holder (for which the Issuer may substitute cash) and has no expiration date.
F5: Includes 66,423 shares of Class B Common Stock issued for each unvested incentive LLC Unit and subject to a right of repurchase in favor of Pluralsight, which will vest on April 17, 2021. In connection with the Offer, the shares of Class B Common Stock and corresponding incentive LLC Units were cancelled and converted into the contingent right to receive a cash payment of $1,494,518, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested incentive LLC Units for which such cash amount was exchanged would have vested pursuant to their terms.
F6: Includes 537,503 shares subject to the option vest in four equal semiannual installments beginning on November 17, 2018. In connection with the Offer, the options were cancelled and converted into a cash payment of $4,031,273, which represents $22.50 for each share of Class A Common Stock subject the options minus the exercise price per share of $15.00, payable in connection with the consummation of the Offer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 21:28 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 9,420 | $104.34 | $982,835.70 |
DisclosureSEC source: 0001338176-26-000038 · form4-10132026_091010.xml · nonDerivative · entry 4 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 296,728 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F5 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $104.02 and the highest price at which shares were sold was $104.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 21:28 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 14,498 | $103.48 | $1,500,253.04 |
DisclosureSEC source: 0001338176-26-000038 · form4-10132026_091010.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,148 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $103.01 and the highest price at which shares were sold was $103.99. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 21:28 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 21,702 | $102.54 | $2,225,281.85 |
DisclosureSEC source: 0001338176-26-000038 · form4-10132026_091010.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 320,646 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $102.01 and the highest price at which shares were sold was $103.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 21:28 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 2,100 | $101.53 | $213,207.12 |
DisclosureSEC source: 0001338176-26-000038 · form4-10132026_091010.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 342,348 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $101.00 and the highest price at which shares were sold was $101.93. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 01, 2026 Filed Oct 2, 2026 02:47 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 4,614 | $97.24 | $448,665.36 |
DisclosureSEC source: 0001338176-26-000036 · form4-10012026_101038.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,448 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 23:38 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 800 | $91.62 | $73,294.00 |
DisclosureSEC source: 0001338176-26-000034 · form4-09112026_110907.xml · nonDerivative · entry 5 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,062 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026. F6 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $91.53 and the highest price at which shares were sold was $91.75. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 23:38 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 5,910 | $90.76 | $536,403.42 |
DisclosureSEC source: 0001338176-26-000034 · form4-09112026_110907.xml · nonDerivative · entry 4 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,862 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026. F5 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $90.45 and the highest price at which shares were sold was $91.42. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 23:38 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 21,783 | $90.05 | $1,961,515.58 |
DisclosureSEC source: 0001338176-26-000034 · form4-09112026_110907.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,772 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $89.45 and the highest price at which shares were sold was $90.445. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 23:38 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 13,807 | $89.00 | $1,228,861.66 |
DisclosureSEC source: 0001338176-26-000034 · form4-09112026_110907.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,555 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $88.44 and the highest price at which shares were sold was $89.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 23:38 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 13,261 | $88.22 | $1,169,923.88 |
DisclosureSEC source: 0001338176-26-000034 · form4-09112026_110907.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,362 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $87.44 and the highest price at which shares were sold was $88.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 20:09 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 9,986 | $92.56 | $924,304.16 |
DisclosureSEC source: 0001338176-26-000032 · form4-09022026_080921.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,623 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| August 24, 2026 Filed Aug 24, 2026 21:32 UTC | Hinge Health, Inc. HNGE · Entity 377 | GiftClass A Common Stock | 11,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-26-000030 · form4-08242026_090847.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,609 Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 22:46 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 4,614 | $74.71 | $344,711.94 |
DisclosureSEC source: 0001338176-26-000028 · form4-08042026_100833.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,172 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:41 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 4,614 | $83.00 | $382,962.00 |
DisclosureSEC source: 0001338176-26-000026 · form4-07022026_080755.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,786 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| June 01, 2026 Filed Jun 1, 2026 23:13 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 9,986 | $56.21 | $561,313.06 |
DisclosureSEC source: 0001338176-26-000024 · form4-06012026_110613.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,400 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| May 26, 2026 Filed May 27, 2026 23:16 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 300 | $55.22 | $16,566.99 |
DisclosureSEC source: 0001338176-26-000022 · form4-05272026_110527.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 445,386 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $55.05 and the highest price at which shares were sold was $55.36. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 26, 2026 Filed May 27, 2026 23:16 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 2,100 | $54.37 | $114,183.93 |
DisclosureSEC source: 0001338176-26-000022 · form4-05272026_110527.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 445,686 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $53.88 and the highest price at which shares were sold was $54.86. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 26, 2026 Filed May 27, 2026 23:16 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 3,507 | $53.32 | $187,006.22 |
DisclosureSEC source: 0001338176-26-000022 · form4-05272026_110527.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 447,786 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $52.88 and the highest price at which shares were sold was $53.85. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:36 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 781 | $55.34 | $43,220.54 |
DisclosureSEC source: 0001338176-26-000020 · form4-05212026_080531.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 451,293 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · balance_after: Includes 781 shares of Class A Common Stock issued to the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:13 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,200 | $55.48 | $66,573.00 |
DisclosureSEC source: 0001338176-26-000016 · form4-05122026_080552.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 386,293 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $55.18 and the highest price at which shares were sold was $56.05. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:13 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 4,706 | $54.65 | $257,185.72 |
DisclosureSEC source: 0001338176-26-000016 · form4-05122026_080552.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 387,493 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $54.14 and the highest price at which shares were sold was $55.13. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:06 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 4,614 | $44.60 | $205,784.40 |
DisclosureSEC source: 0001338176-26-000014 · form4-05042026_080506.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,199 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| April 29, 2026 Filed May 20, 2026 01:18 UTC | Hinge Health, Inc. HNGE · Entity 377 | GrantClass A Common Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-26-000018 · form4-05202026_010516.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,293 F1 · kind: Represents a restricted stock unit ("RSU") award that was acquired through an exempt transaction with the Issuer. Each RSU represents a right to receive one share of the Issuer's Class A Common Stock at the time of vesting for no consideration. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:23 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 4,614 | $38.56 | $177,915.84 |
DisclosureSEC source: 0001338176-26-000012 · form4-04012026_080419.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,813 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 23:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 672 | $42.80 | $28,763.15 |
DisclosureSEC source: 0001338176-26-000010 · form4-03242026_110334.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 401,427 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $42.78 and the highest price at which shares were sold was $42.87. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 23:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 8,346 | $42.45 | $354,299.38 |
DisclosureSEC source: 0001338176-26-000010 · form4-03242026_110334.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,099 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $41.78 and the highest price at which shares were sold was $42.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 23:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,988 | $41.29 | $82,076.17 |
DisclosureSEC source: 0001338176-26-000010 · form4-03242026_110334.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,445 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $40.73 and the highest price at which shares were sold was $41.69. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 7,699 | $42.76 | $329,209.24 |
DisclosureSEC source: 0001338176-26-000008 · form4-03032026_100341.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 412,433 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 900 | $40.43 | $36,388.98 |
DisclosureSEC source: 0001338176-26-000006 · form4-02242026_090219.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420,132 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $40.40 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 6,297 | $39.90 | $251,271.08 |
DisclosureSEC source: 0001338176-26-000006 · form4-02242026_090219.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 421,032 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $39.40 and the highest price at which shares were sold was $40.39. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:20 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 7,566 | $38.74 | $293,077.33 |
DisclosureSEC source: 0001338176-26-000006 · form4-02242026_090219.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 427,329 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $38.40 and the highest price at which shares were sold was $39.37. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 01:44 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 3,036 | $34.90 | $105,956.40 |
DisclosureSEC source: 0001338176-26-000004 · form4-02042026_010211.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,895 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:33 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 3,243 | $46.45 | $150,637.35 |
DisclosureSEC source: 0001338176-26-000002 · form4-01052026_090123.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,931 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:17 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 10,491 | $48.41 | $507,836.79 |
DisclosureSEC source: 0001338176-25-000016 · form4-12232025_091225.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,174 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $47.81 and the highest price at which shares were sold was $48.74. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 23:03 UTC | Hinge Health, Inc. HNGE · Entity 377 | GiftClass A Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-25-000014 · form4-12122025_111245.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,665 Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 21:06 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 8,213 | $48.91 | $401,697.83 |
DisclosureSEC source: 0001338176-25-000012 · form4-12012025_091231.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,665 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 01:06 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,611 | $48.27 | $77,769.09 |
DisclosureSEC source: 0001338176-25-000010 · form4-11262025_011124.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 479,878 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F4 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $48.25 and the highest price at which shares were sold was $48.33. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 01:06 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 27,248 | $47.77 | $1,301,552.49 |
DisclosureSEC source: 0001338176-25-000010 · form4-11262025_011124.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 481,489 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $47.25 and the highest price at which shares were sold was $48.24. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 01:06 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 15,730 | $46.88 | $737,457.01 |
DisclosureSEC source: 0001338176-25-000010 · form4-11262025_011124.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 508,737 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $46.25 and the highest price at which shares were sold was $47.24. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:10 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 781 | $44.78 | $34,973.18 |
DisclosureSEC source: 0001338176-25-000008 · form4-11212025_091153.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 524,467 F1 · kind: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 21:51 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingClass A Common Stock | 34,903 | $40.84 | $1,425,438.52 |
DisclosureSEC source: 0001338176-25-000006 · form4-11192025_091142.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,248 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. F2 · balance_after: Includes 781 shares of Class A Common Stock acquired by the Reporting Person on November 14, 2025 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| May 23, 2025 Filed May 23, 2025 21:21 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherClass A Common Stock | 559,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077110 · ownership.xml · nonDerivative · entry 4 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,370 F3 · kind: Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · price: Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. F4 · balance_after: Includes 387,084 RSUs, which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock. Read SEC document |
| May 23, 2025 Filed May 23, 2025 21:21 UTC | Hinge Health, Inc. HNGE · Entity 377 | OtherCommon Stock | 559,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077110 · ownership.xml · nonDerivative · entry 3 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · kind: Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · price: Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:21 UTC | Hinge Health, Inc. HNGE · Entity 377 | Tax withholdingCommon Stock | 135,070 | $32.00 | $4,322,240.00 |
DisclosureSEC source: 0000950170-25-077110 · ownership.xml · nonDerivative · entry 2 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,370 Read SEC document |
| April 29, 2025 Filed May 23, 2025 21:21 UTC | Hinge Health, Inc. HNGE · Entity 377 | GrantCommon Stock | 91,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077110 · ownership.xml · nonDerivative · entry 1 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,440 F1 · shares: Reflects an award of restricted stock units ("RSUs"), which vests as to 3.125% of the total award each quarter for the first two years, and as to 9.375% of the total award each quarter thereafter until fully vested at the fourth anniversary of the vesting commencement date. Each RSU represents a contingent right to receive one share of Class A Common Stock following the reclassification of the Issuer's Common Stock. F2 · balance_after: These securities were previously reported on a Form 3 filed by the Reporting Person. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:14 UTC | Pluralsight, Inc. PS · Entity 140372 | OtherEmployee Stock Option (right to buy) · Derivative | 537,503 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001338176-21-000014 · wf-form4_161793084678393.xml · derivative · entry 8 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 537,503 shares Expires 2028-05-17 F6 · derivative.exercise_price: Includes 537,503 shares subject to the option vest in four equal semiannual installments beginning on November 17, 2018. In connection with the Offer, the options were cancelled and converted into a cash payment of $4,031,273, which represents $22.50 for each share of Class A Common Stock subject the options minus the exercise price per share of $15.00, payable in connection with the consummation of the Offer. F6 · derivative.exercise_date: Includes 537,503 shares subject to the option vest in four equal semiannual installments beginning on November 17, 2018. In connection with the Offer, the options were cancelled and converted into a cash payment of $4,031,273, which represents $22.50 for each share of Class A Common Stock subject the options minus the exercise price per share of $15.00, payable in connection with the consummation of the Offer. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:14 UTC | Pluralsight, Inc. PS · Entity 140372 | OtherClass B Common Stock · Derivative | 66,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-21-000014 · wf-form4_161793084678393.xml · derivative · entry 7 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 66,423 shares Expires not disclosed F5 · derivative.exercise_price: Includes 66,423 shares of Class B Common Stock issued for each unvested incentive LLC Unit and subject to a right of repurchase in favor of Pluralsight, which will vest on April 17, 2021. In connection with the Offer, the shares of Class B Common Stock and corresponding incentive LLC Units were cancelled and converted into the contingent right to receive a cash payment of $1,494,518, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested incentive LLC Units for which such cash amount was exchanged would have vested pursuant to their terms. F5 · derivative.exercise_date: Includes 66,423 shares of Class B Common Stock issued for each unvested incentive LLC Unit and subject to a right of repurchase in favor of Pluralsight, which will vest on April 17, 2021. In connection with the Offer, the shares of Class B Common Stock and corresponding incentive LLC Units were cancelled and converted into the contingent right to receive a cash payment of $1,494,518, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested incentive LLC Units for which such cash amount was exchanged would have vested pursuant to their terms. F5 · derivative.expiration_date: Includes 66,423 shares of Class B Common Stock issued for each unvested incentive LLC Unit and subject to a right of repurchase in favor of Pluralsight, which will vest on April 17, 2021. In connection with the Offer, the shares of Class B Common Stock and corresponding incentive LLC Units were cancelled and converted into the contingent right to receive a cash payment of $1,494,518, which represents $22.50 for each outstanding unvested unit, which will vest and be payable at the same time as the unvested incentive LLC Units for which such cash amount was exchanged would have vested pursuant to their terms. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:14 UTC | Pluralsight, Inc. PS · Entity 140372 | Exercise / conversionClass B Common Stock · Derivative | 150,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-21-000014 · wf-form4_161793084678393.xml · derivative · entry 6 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,423 Underlying: Class A Common Stock · 150,080 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: One share of the Issuer's Class B common stock (the "Class B Common Stock") was issued for each limited liability company unit of Pluralsight Holdings, LLC (each an "LLC Unit") held by the reporting person pursuant to a reclassification of Pluralsight Holdings, LLC that occurred prior to the Issuer's initial public offering. The shares of Class B Common Stock (i) confer no incidents of economic ownership on the holders thereof and (ii) only confer one-to-one voting rights on the holders thereof. Each share of Class B Common Stock and corresponding LLC Unit is redeemable or exchangeable for one share of Class A Common Stock at the option of the holder (for which the Issuer may substitute cash) and has no expiration date. F4 · derivative.exercise_date: One share of the Issuer's Class B common stock (the "Class B Common Stock") was issued for each limited liability company unit of Pluralsight Holdings, LLC (each an "LLC Unit") held by the reporting person pursuant to a reclassification of Pluralsight Holdings, LLC that occurred prior to the Issuer's initial public offering. The shares of Class B Common Stock (i) confer no incidents of economic ownership on the holders thereof and (ii) only confer one-to-one voting rights on the holders thereof. Each share of Class B Common Stock and corresponding LLC Unit is redeemable or exchangeable for one share of Class A Common Stock at the option of the holder (for which the Issuer may substitute cash) and has no expiration date. F4 · derivative.expiration_date: One share of the Issuer's Class B common stock (the "Class B Common Stock") was issued for each limited liability company unit of Pluralsight Holdings, LLC (each an "LLC Unit") held by the reporting person pursuant to a reclassification of Pluralsight Holdings, LLC that occurred prior to the Issuer's initial public offering. The shares of Class B Common Stock (i) confer no incidents of economic ownership on the holders thereof and (ii) only confer one-to-one voting rights on the holders thereof. Each share of Class B Common Stock and corresponding LLC Unit is redeemable or exchangeable for one share of Class A Common Stock at the option of the holder (for which the Issuer may substitute cash) and has no expiration date. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:14 UTC | Pluralsight, Inc. PS · Entity 140372 | OtherClass A Common Stock | 150,080 | $22.50 | $3,376,800.00 |
DisclosureSEC source: 0001338176-21-000014 · wf-form4_161793084678393.xml · nonDerivative · entry 5 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:14 UTC | Pluralsight, Inc. PS · Entity 140372 | Exercise / conversionClass A Common Stock | 150,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001338176-21-000014 · wf-form4_161793084678393.xml · nonDerivative · entry 4 Budge James · CIK 0001338176 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposed of pursuant to the cash tender offer (the "Offer") made pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated March 7, 2021, by and among Lake Holdings, LP, Lake Guarantor, LLC, Lake Merger Sub I, Inc., Lake Merger Sub II, LLC, Pluralsight, Inc., and Pluralsight Holdings, LLC ("Holdings"), a copy of which is filed as Exhibit 2.1 to the Issuer's Form 8-K filed with the SEC on March 8, 2021. In connection with the Offer, the Reporting Person redeemed LLC Units and corresponding Class B Common Stock for Class A Common Stock in accordance with the Fourth Amended and Restated Limited Liability Company Agreement of Holdings, and exercised vested options, and tendered in the Offer all of such Reporting Person's Class A Common Stock (including shares issuable with respect to the redemption of LLC Units and the exercise of vested options). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.